UXOO7 for GLUT-1 Deficiency
Project Description:
A randomized, double-blind, placebo-controlled, parallel-group, adaptive study to assess the safety and efficacy of UX007 in subjects with glucose transporter Type 1 deficiency syndrome. Funding from March 2014 - March 2016.
Core Function(s):
Performing Research or Evaluation
Area of Emphasis
Health-Related Activities, Quality of Life
Target Audience:
Professionals and Para-Professionals, Family Members/Caregivers, General Public
Unserved or Under-served Populations:
None
Primary Target Audience Geographic Descriptor:
Mulit-County
COVID-19 Related Data:
N/A